OBALON THERAPEUTICS INC | Credit Agreements | Business Contracts

Credit Agreement, dated March 25, 2020, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on March 30, 2021)

Second Amendment to Credit Agreement, dated September 14, 2020, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on March 30, 2021)

Third Amendment to Credit Agreement, dated December 16, 2020, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on March 30, 2021)

Credit Facility Agreement, dated as of January 19, 2021, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on March 30, 2021)

Fourth Amendment to Credit Agreement, dated January 19, 2021, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on March 30, 2021)

OBALON THERAPEUTICS INC (65) | Credit Agreements (5)